Alla Volgina

INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models

Phillip C.C. Liu, Holly K. Koblish, Liangxing Wu et al. · PLoS ONE · 2020 · 161 citations · Full text

Medicine, Oncology, Pharmacology +14

A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade

Cecile Geuijen, Paul J. Tacken, Liang-Chuan Wang et al. · Nature Communications · 2021 · 114 citations · Full text

Life Sciences, Immunology, Oncology +17

Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.

Whitney P. Bowe, Jennifer Filip, Joseph M. DiRienzo et al. · PubMed · 2006 · 73 citations

Life Sciences, Microbiology, Antimicrobial Resistance +12

Targeted Inhibition of CD133 ⁺ Cells in Oral Cancer Cell Lines

Monika Damek-Poprawa, Alla Volgina, J M Korostoff et al. · Journal of Dental Research · 2011 · 65 citations · Full text

Medicine, Cell Biology, Oncology +13

The Novel Bromodomain and Extraterminal Domain Inhibitor INCB054329 Induces Vulnerabilities in Myeloma Cells That Inform Rational Combination Strategies

Matthew C. Stubbs, Timothy C. Burn, Richard Sparks et al. · Clinical Cancer Research · 2018 · 49 citations

Medicine, Oncology, Pharmacology +16